Cumberland Pharmaceuticals Inc (CPIX) Stock Analysis

Cumberland Pharmaceuticals Inc (CPIX) is a publicly traded company in the HEALTHCARE sector. It trades at $5.77, carries a market capitalization of $85.40M. This page summarizes the public market data, fundamentals, and frequently asked questions for CPIX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Cumberland Pharmaceuticals Inc currently has a Bullish sentiment score of 0.32.

About Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc. (CPIX) is a specialty pharmaceutical company headquartered in Nashville, Tennessee, specializing in the acquisition, development, and commercialization of innovative prescription products for acute care settings, gastroenterology, and rheumatology. The company is committed to addressing unmet medical needs, enhancing patient outcomes, and improving hospital efficiencies through its diverse portfolio and robust pipeline. With a strategic focus on delivering qual...

GNG Research Analysis

GNG Research scores Cumberland Pharmaceuticals Inc (CPIX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CPIX.

Frequently Asked Questions

Does CPIX pay dividends?

Cumberland Pharmaceuticals Inc (CPIX) does not currently pay a regular dividend.

What is CPIX's market cap?

Cumberland Pharmaceuticals Inc (CPIX) has a market capitalization of $85.40M with a current stock price of $5.77.